The potential of a multiplex high-throughput molecular assay for early detection of first and second line tuberculosis drug resistance mutations to improve infection control and re...

por van’t Hoog, AH, Bergval, I., Tukvadze, N., Sengstake, S., Aspindzelashvili, R., Anthony, RM, Cobelens, F.
Publicado 2015

Does BCG vaccination protect against infection with M. tuberculosis?

por Pelzer, P. T., Smit, Y., Tiemersma, E.W., Huong, N. T., Nhung, N. V., Cobelens, F.
Publicado 2022

Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling

por Dowdy, D. W., Houben, R., Cohen, T., Pai, M., Cobelens, F., Vassall, A., Menzies, N. A., Gomez, G. B., Langley, I., Squire, S. B., White, R.
Publicado 2014

Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis

por Gomez, G. B., Dowdy, D. W., Bastos, M. L., Zwerling, A., Sweeney, S., Foster, N., Trajman, A., Islam, M. A., Kapiga, S., Sinanovic, E., Knight, G. M., White, R. G., Wells, W. A., Cobelens, F. G., Vassall, A.
Publicado 2016